When the world gets closer.

We help you see farther.

Sign up to our expressly international daily newsletter.

Already a subscriber? Log in.

You've reach your limit of free articles.

Get unlimited access to Worldcrunch

You can cancel anytime.

SUBSCRIBERS BENEFITS

Ad-free experience NEW

Exclusive international news coverage

Access to Worldcrunch archives

Monthly Access

30-day free trial, then $2.90 per month.

Annual Access BEST VALUE

$19.90 per year, save $14.90 compared to monthly billing.save $14.90.

Subscribe to Worldcrunch
CORRIERE DELLA SERA

Growing Evidence Of COVID-19's Neurological Impact

COVID-19 is still a largely mysterious pandemic
COVID-19 is still a largely mysterious pandemic
Carl-Johan Karlsson

The most common symptoms are fever, a dry cough and loss of taste and smell. The majority of deaths are due to respiratory failure. But more studies about COVID-19 are now focusing on neurological factors in what is still a largely mysterious pandemic. In the last few weeks, findings from around the world give support for earlier indications of coronavirus infections being linked to the brain.

  • Sweden: A study from the University of Gothenburg shows that certain patients in ICU care have suffered brain damage, reports daily Stockholm-based Svenska Dagbladet. Doctors already knew that severe infections impaired cognitive abilities, but it turns out that even patients not in need of respiratory assistance have experienced similar complications. Swedish scientists are now investigating whether the damage is caused directly by the virus or by immune system failure.
  • Italy: Up to 30% of COVID-19 patients have had some impact on the brain, according to Professor Alessandro Padovani, head of the neurology unit at the University of Brescia, who launched a "NeuroCovid" center to study the effects of the virus on the brain. Padovani told Corriere della Sera that the impact on the brain of COVID-19 patients is a more severe version of the potential neurological risks of a typical flu, particularly for the elderly, including a 1.5% higher likelihood of suffering a stroke. This is one of the reasons it is advisable to get a flu shot, Padovani said.

Inside the COVID department of a hospital in Palermo, Italy — Photo: Igor Petyx/IPA/ZUMA

  • France: Director general of health Jérôme Salomon confirmed in April that neurologic lesions were often identified in patients in intensive care — lesions that were sometimes temporary and sometimes permanent. The first symptoms of neurologic lesions that were highlighted in France were anosmia and ageusia, alteration of the sense of smell and the loss of taste functions.
  • UnitedStates: In some cases, impaired respiration is due to damage in the brain center that controls breathing, according to findings from a research team from Case Western Reserve University School of Medicine in Cleveland. They also identified an inflammation in the area of ​​the brain that determines the respiratory rate. The study shows that injecting anti-inflammatory drugs into the central nervous system reduces inflammation both in the brain and in the lungs.
  • China: A Chinese study published in the Journal of Medical Virology also suggests that SARS-CoV-2 can induce neuronal damage. The study compared the novel coronavirus to previous ones, like HEV67 and avian bronchitis virus, which can first invade the peripheral nerve endings and then access the nervous system.

You've reached your limit of free articles.

To read the full story, start your free trial today.

Get unlimited access. Cancel anytime.

Exclusive coverage from the world's top sources, in English for the first time.

Insights from the widest range of perspectives, languages and countries.

Worldcrunch Magazine #37 — Iran And The Taliban: The Drug Connection
Worldcrunch

This is the latest edition of Worldcrunch Magazine, a selection of our best articles of the week from the best international journalists, produced exclusively in English for Worldcrunch readers.

>> DISCOVER IT HERE <<

Keep reading...Show less

You've reached your limit of free articles.

To read the full story, start your free trial today.

Get unlimited access. Cancel anytime.

Exclusive coverage from the world's top sources, in English for the first time.

Insights from the widest range of perspectives, languages and countries.

Already a subscriber? Log in.

You've reach your limit of free articles.

Get unlimited access to Worldcrunch

You can cancel anytime.

SUBSCRIBERS BENEFITS

Ad-free experience NEW

Exclusive international news coverage

Access to Worldcrunch archives

Monthly Access

30-day free trial, then $2.90 per month.

Annual Access BEST VALUE

$19.90 per year, save $14.90 compared to monthly billing.save $14.90.

Subscribe to Worldcrunch

The latest